Evidence map›Paper›PMID 26636762›Full record

ArticlePloS one2015

Treatment Planning and Delivery of Whole Brain Irradiation with Hippocampal Avoidance in Rats.

C K Cramer, S W Yoon, M Reinsvold, K M Joo, H Norris, R C Hood, J D Adamson, R C Klein, D G Kirsch, M Oldham

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

C K CramerDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
S W YoonDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
M ReinsvoldDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
K M JooDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
H NorrisDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
R C HoodDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
J D AdamsonDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
R C KleinDepartment of Psychiatry, Durham VA, Durham, NC, United States of America.
D G KirschDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
M OldhamDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC, United States of America.
Duke Medical Center · USDuke University Hospital · US

Funding

Independent Scientist Award for Radiation ResearchK02AI093866 · NIAID · DUKE UNIVERSITY · PI KIRSCH, DAVID GUY · 2011 to 2015
$501k
NIAID NIH HHS K02 AI093866
6 · The paper itself

Abstract

backgroundDespite the clinical benefit of whole brain radiotherapy (WBRT), patients and physicians are concerned by the long-term impact on cognitive functioning. Many studies investigating the molecular and cellular impact of WBRT have used rodent models. However, there has not been a rodent protocol comparable to the recently reported Radiation Therapy Oncology Group (RTOG) protocol for WBRT with hippocampal avoidance (HA) which is intended to spare cognitive function. The aim of this study was to develop a hippocampal-sparing WBRT protocol in Wistar rats.

methodsThe technical and clinical challenges encountered in hippocampal sparing during rat WBRT are substantial. Three key challenges were identified: hippocampal localization, treatment planning, and treatment localization. Hippocampal localization was achieved with sophisticated imaging techniques requiring deformable registration of a rat MRI atlas with a high resolution MRI followed by fusion via rigid registration to a CBCT. Treatment planning employed a Monte Carlo dose calculation in SmART-Plan and creation of 0.5 cm thick lead blocks custom-shaped to match DRR projections. Treatment localization necessitated the on-board image-guidance capability of the XRAD C225Cx micro-CT/micro-irradiator (Precision X-Ray). Treatment was accomplished with opposed lateral fields with 225 KVp X-rays at a current of 13 mA filtered through 0.3 mm of copper using a 40x40 mm square collimator and the lead blocks. A single fraction of 4 Gy was delivered (2 Gy per lateral field) with a 41 second beam on time per field at a dose rate of 304.5 cGy/min. Dosimetric verification of hippocampal sparing was performed using radiochromic film. In vivo verification of HA was performed after delivery of a single 4 Gy fraction either with or without HA using γ-H2Ax staining of tissue sections from the brain to quantify the amount of DNA damage in rats treated with HA, WBRT, or sham-irradiated (negative controls).

resultsThe mean dose delivered to radiochromic film beneath the hippocampal block was 0.52 Gy compared to 3.93 Gy without the block, indicating an 87% reduction in the dose delivered to the hippocampus. This difference was consistent with doses predicted by Monte Carlo dose calculation. The Dose Volume Histogram (DVH) generated via Monte Carlo simulation showed an underdose of the target volume (brain minus hippocampus) with 50% of the target volume receiving 100% of the prescription isodose as a result of the lateral blocking techniques sparing some midline thalamic and subcortical tissue. Staining of brain sections with anti-phospho-Histone H2A.X (reflecting double-strand DNA breaks) demonstrated that this treatment protocol limited radiation dose to the hippocampus in vivo. The mean signal intensity from γ-H2Ax staining in the cortex was not significantly different from the signal intensity in the cortex of rats treated with WBRT (5.40 v. 5.75, P = 0.32). In contrast, the signal intensity in the hippocampus of rats treated with HA was significantly lower than rats treated with WBRT (4.55 v. 6.93, P = 0.012).

conclusionDespite the challenges of planning conformal treatments for small volumes in rodents, our dosimetric and in vivo data show that WBRT with HA is feasible in rats. This study provides a useful platform for further application and refinement of the technique.

Indexed as

AnimalsCranial IrradiationDNADose Fractionation, RadiationHippocampusRadiotherapy, Intensity-ModulatedRatsRats, WistarTreatment OutcomeDNA

Identifiers

PMID26636762
PMCPMC4670078
OpenAlexW2187551702

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.